Coya Therapeutics
COYA
26 hedge funds and large institutions have $30.2M invested in Coya Therapeutics in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
18% more capital invested
Capital invested by funds: $25.5M → $30.2M (+$4.7M)
1.27% more ownership
Funds ownership: 26.6% → 27.87% (+1.3%)
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$1.06M |
| 2 |
CM
CM Management
Gulf Breeze,
Florida
|
+$253K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$215K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$179K |
| 5 |
PWM
Prosperity Wealth Management
San Ramon,
California
|
+$102K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$401K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$110K |
| 3 |
MCP
Mirador Capital Partners
Pleasanton,
California
|
-$79.1K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$59K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$56.6K |
COYA Hedge Fund Activity: Q1 2025 in Review
26 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Coya Therapeutics (COYA) for Q1 2025, worth a combined $30.2M — up 18% from $25.5M a quarter earlier.
Fund positioning in COYA was balanced in Q1 2025: 5 funds opened new positions, 5 closed out, 10 added to existing stakes and 4 trimmed.
The largest buyer was Dauntless Investment Group, opening a new position worth an estimated $1.06M. The largest seller was Newbridge Financial Services Group, exiting entirely with an estimated $401K sold.
- 26 institutional investors held Coya Therapeutics (COYA) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $30.2M of Coya Therapeutics stock for Q1 2025, up 18% quarter-over-quarter.
- 5 funds opened new Coya Therapeutics positions in Q1 2025 and 5 closed out, a net change of 0 holders.
- The largest Coya Therapeutics buyer in Q1 2025 was Dauntless Investment Group, an estimated $1.06M added.
- The largest Coya Therapeutics seller in Q1 2025 was Newbridge Financial Services Group, an estimated $401K sold.
Based on aggregated 13F filings for Q1 2025.